Optimization of process conditions and kinetic microbial growth for milk fermentation using domestic kefir grains from Costa Rica

利用哥斯达黎加国产开菲尔菌粒优化牛奶发酵工艺条件和微生物生长动力学

阅读:1

Abstract

Kefir, a fermented milk product, differs from yogurt due to its unique microbial composition, offering a broad spectrum of health benefits. Given its global popularity and high cost, there is a significant trend towards domestic kefir production. This study explores the optimization of kefir fermentation using Costa Rican domestic kefir grains, assessing the effects of temperature, agitation, and initial starter culture concentration. A central composite rotatable design and response surface statistical approach were employed to evaluate these parameters. Microbial growth data were fitted into a quadratic model, revealing significant interactions, particularly with temperature affecting both lactic acid bacteria (LAB) and yeast populations. Optimized fermentation conditions were established at 25°C, 0 rpm, and 5 g/L initial biomass, under which final microbial populations reached 9.45±0.13 log(cfu)/mL for yeast and 9.23±0.06 log(cfu)/mL for LAB. The specific growth velocity for kefir biomass was 0.029 1/h, and the total acid production rate was 0.060 g/(L h). Notably, the acetic acid production was significantly less than lactic acid, indicating a dominance of LAB over acetic acid bacteria, which is crucial for the desired flavor and health benefits of kefir. Additionally, microbial enumeration on glucose-yeast extract, calcium carbonate agar, and Rogosa agar showed distinct colony formations, highlighting the complex microbial interactions within kefir. This comprehensive dataset suggests that the performance of non-commercial starter cultures can be significantly improved under controlled conditions, providing a basis for developing guidelines for domestic kefir production. This study not only optimizes kefir production but also ensures that home-prepared kefir can meet quality standards, potentially enhancing its nutritional and therapeutic benefits.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。